Last Posted: Mar 08, 2019
- Pharmacogenetics—the future is networks
K Walsh, BMJ, March 7, 2019 - Pharmacogenomic and Pharmacotranscriptomic Profiling of Childhood Acute Lymphoblastic Leukemia: Paving the Way to Personalized Treatment.
Pavlovic Sonja et al. Genes 2019 Mar 10(3) - Early Lessons from the Implementation of Genomic Medicine Programs.
Williams Marc S et al. Annual review of genomics and human genetics 2019 Feb - CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset.
Damkier Per et al. Scientific reports 2017 7(1) 7727 - Genetic predictors of efficacy and toxicity of iguratimod in patients with rheumatoid arthritis.
Xiao Wenjing et al. Pharmacogenomics 2018 19(5) 383-392 - The pharmacoepigenomics informatics pipeline defines a pathway of novel and known warfarin pharmacogenomics variants.
Allyn-Feuer Ari et al. Pharmacogenomics 2018 19(5) 413-434 - What is pharmacogenomics?
Genetics Home Reference, 2019 - Precision dosing of warfarin: open questions and strategies.
Li Xi et al. The pharmacogenomics journal 2019 Feb - Effects of genetic variability on rifampicin and isoniazid pharmacokinetics in South African patients with recurrent tuberculosis.
Naidoo Anushka et al. Pharmacogenomics 2019 Feb - Clinical Review of the Pharmacogenomics of Direct Oral Anticoagulants.
Tseng Andrew S et al. Cardiovascular drugs and therapy 2018 32(1) 121-126
.png)
No hay comentarios:
Publicar un comentario